FDA Restricts Gene Therapy Skysona Due to Blood Cancer Risk

(MedPage Today) — The FDA approved labeling changes for elivaldogene autotemcel (eli-cel; Skysona), a one-time gene therapy for patients with early, active cerebral adrenoleukodystrophy (CALD), to reflect new safety information about hematologic…